Showing 1–16 of 17 results
Identify key stakeholders and personas Focus on key opinion leaders and key outcomes leaders (KOLs) Conduct secondary research on stakeholder perspectives on value. Conduct primary research (e.g., focus groups, in-depth interviews). Run social listening. Tabulate stakeholders, personas, and their value-related preferences.
Characterize value propositions. Review internal and known external datasets. Review proof-of-value content (e.g., publications, marketing materials, competitive analyses). Summarize current value proposition. Synthesize a better value proposition. Craft a best-case (ideal) value proposition. Identify proof-of-value gap. Identify data and evidence needs for study design and/or optimizing the proof-of-value.
Build mastery of value-based healthcare (VBHC) and the societal, business, and clinical implications and imperatives associated with the volume-to-value (V2V) transition.
Characterize the state-of-the-art relative to VBHC and ECHOs for the condition, product-category, and/or product. Forces (e.g., activist employers) Disruptors (e.g., www.icer-review.org) Transition speed (e.g., value-based revenue growth) Enterprises (e.g., competitors) KOLs Initiatives (e.g., VBCs, OBC) Implications (e.g., demand for proof of value) Imperatives (e.g., case for value)
Build insight into economic, clinical, and humanistic outcomes (ECHOs) for the targeted condition, product-category, or product within a VBHC environment.
Compile competitive VBHC and ECHO content. Create a content development and syndication plan to outperform the competition.
Identify desired benefits (e.g., reduced hospitalizations, improved activities of daily living [ADL] score). Confirm cost per unit of benefit. Build the cost-benefit story.
Identify measures of effectiveness and/or utility (e.g., cost per quality adjusted life year [QALY]. Confirm cost and effectiveness/utility (e.g., Treatment A vs. Treatment B). Build the case for superior cost-effectiveness or cost-utility (e.g., clinical trial, practice-based research, claims analytics).
Document incremental cost or savings around a new product, service, or solution. Identify stakeholder(s) and perspective(s). Quantify disease incidence and prevalence. Identify comparators (e.g., Treatment A vs. Treatment B). Note cost drivers (e.g., people, products, processes). Quantify budgetary effects.
Characterize inputs, processes, outcomes, and costs of the following: Disease progression, comorbidities, and complications Diagnostic pathways Treatment pathways Palliative care pathways Other pathways Confirm the least costly approach.
Audit the following units against VBHC best practices: Corporate Governance Executive Leadership Strategic Alliances R&D Team / Opportunity Validation Team Portfolio Design and Management Team Business Development Team Brand Team Medical Affairs Team HEOR/CER, RWD/RWE, and/or Value Teams Market Access / Reimbursement Team Commercial Affairs Team Ad Agency
Build an understanding of key VBHC functions within the organization, that are essential for the V2V transition (e.g., HEOR/CER, RWD/RWE, VBC/OBC, impact accountability).
Suggest refinements to the corporate mission, vision, objectives, strategies, policies, structures, systems, processes, procedures, and standards. Identify key performance indicators (KPIs). Describe the ideal approach to measurement, reporting, and continuous improvement.
Build technical knowledge of breakthroughs and best practices in health economics and outcomes research (HEOR), comparative-effectiveness research (CER), real-world data (RWD) and real-world evidence (RWE) alliances, value-based contracts (VBCs), outcomes-based compensation (OBC), and impact accountability.
Identify targeted third-party payers, third-party administrators, health plan purchasers, healthcare provider organizations, healthcare professionals, etc. Identify key opinion leaders and key outcomes leaders (KOLs). Traditional Social Media Identify compelling media and channels Package proof-of-value content in preferred media for distribution via preferred channels. Implement the proof-of-value campaign.
Industry, market, and competitive reports on the volume-to-value (V2V) transition. Characterize the VBHC environment, including the following: Market drivers (e.g., constrained resources) Forces (e.g., activist employers) Disruptors (e.g., www.icer-review.org) Transition speed (e.g., value-based revenue growth) Enterprises (e.g., competitors) Key opinion leaders and key outcome leaders (e.g., KOLs) Initiatives (e.g., value-based contracts [VBCs], outcomes-based compensation [OBC])…